Initial guidance for head and neck cancer management during Covid-19 pandemic in consultation with ENT UK. BAOMS endorsement awaited.

Last Updated on


BAHNO position:

Healthcare services internationally are seeking to meet and manage the unprecedented impact of the Covid-19 pandemic.

The following is guidance for the provisioning of head and neck (H&N) cancer services during this period. It is intended to guide and support decisions made locally/regionally within H&N MDTs. These should not be viewed as being prescriptive, rather as a support for local decision making and should be used alongside Department of Health guidance. They will be updated as priorities and understanding of the situation evolves.

Leave a Comment

Your email address will not be published. Required fields are marked *